Associations of home and workplace vaping restrictions with e-cigarette use among U.S. adults.
Population Clinical
Consumer Use
Factors Influencing Pattern Of Use
Azagba (2020)
E-Cigarette Use and Transition in Adult Smoking Frequency: A Longitudinal Study.
Population Clinical
Likelihood Of Use
Former Smokers Initiating ENDs
Azagba (2020)
Associations between e-cigarette pack size and vaping frequency among U.S. adults.
Population Clinical
Consumer Use
Factors Influencing Pattern Of Use
Azagba (2021)
Is socioeconomic status related to youth e-cigarette use? Examining family affluence and sexual identity.
Population Clinical
Consumer Use
Factors Influencing Pattern Of Use
Azagba (2023)
an Unrecognized hazard in E-Cigarette Vapor: Preliminary quantification of Methylglyoxal Formation from Propylene Glycol in E-Cigarettes.
Nonclinical
Chemical
Analysis
azimi (2021)
A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Azzopardi (2022)
Chemical characterization of tobacco-free "modern" oral nicotine pouches and their position on the toxicant and risk continuums
Non-Clinical
Chemical
Analysis
Azzopardi (2022)
Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Azzopardi (2023)
Young people's perceptions of tobacco packaging: a comparison of EU Tobacco Products Directive & Ireland's Standardisation of Tobacco act
Population Clinical
Effect Of Packaging And Labeling On Perception Of Risk
Youth Use And Appeal
Babineau (2015)
Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs)
Individual Clinical
Safety
Adverse Effects
Back (2023)